Suppr超能文献

美国国立综合癌症网络(NCCN)指南解读:膀胱癌,2016年第2版

NCCN Guidelines Insights: Bladder Cancer, Version 2.2016.

作者信息

Clark Peter E, Spiess Philippe E, Agarwal Neeraj, Bangs Rick, Boorjian Stephen A, Buyyounouski Mark K, Efstathiou Jason A, Flaig Thomas W, Friedlander Terence, Greenberg Richard E, Guru Khurshid A, Hahn Noah, Herr Harry W, Hoimes Christopher, Inman Brant A, Kader A Karim, Kibel Adam S, Kuzel Timothy M, Lele Subodh M, Meeks Joshua J, Michalski Jeff, Montgomery Jeffrey S, Pagliaro Lance C, Pal Sumanta K, Patterson Anthony, Petrylak Daniel, Plimack Elizabeth R, Pohar Kamal S, Porter Michael P, Sexton Wade J, Siefker-Radtke Arlene O, Sonpavde Guru, Tward Jonathan, Wile Geoffrey, Dwyer Mary A, Smith Courtney

机构信息

From Vanderbilt-Ingram Cancer Center; Moffitt Cancer Center; Huntsman Cancer Institute at the University of Utah; Patient Advocate; Mayo Clinic Cancer Center; Stanford Cancer Institute; Massachusetts General Hospital Cancer Center; University of Colorado Cancer Center; UCSF Helen Diller Family Comprehensive Cancer Center; Fox Chase Cancer Center; Roswell Park Cancer Institute; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Memorial Sloan Kettering Cancer Center; Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute; Duke Cancer Institute; UC San Diego Moores Cancer Center; Dana-Farber/Brigham and Women's Cancer Center; Robert H. Lurie Comprehensive Cancer Center of Northwestern University; Fred & Pamela Buffett Cancer Center; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; University of Michigan Comprehensive Cancer Center; City of Hope Comprehensive Cancer Center; St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; Yale Cancer Center/Smilow Cancer Hospital; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; University of Washington/Seattle Cancer Care Alliance; The University of Texas MD Anderson Cancer Center; University of Alabama at Birmingham Comprehensive Cancer Center; and National Comprehensive Cancer Network.

出版信息

J Natl Compr Canc Netw. 2016 Oct;14(10):1213-1224. doi: 10.6004/jnccn.2016.0131.

Abstract

These NCCN Guidelines Insights discuss the major recent updates to the NCCN Guidelines for Bladder Cancer based on the review of the evidence in conjunction with the expert opinion of the panel. Recent updates include (1) refining the recommendation of intravesical bacillus Calmette-Guérin, (2) strengthening the recommendations for perioperative systemic chemotherapy, and (3) incorporating immunotherapy into second-line therapy for locally advanced or metastatic disease. These NCCN Guidelines Insights further discuss factors that affect integration of these recommendations into clinical practice.

摘要

这些美国国立综合癌症网络(NCCN)指南见解基于证据审查并结合专家组的专家意见,讨论了NCCN膀胱癌指南近期的主要更新内容。近期更新包括:(1)完善卡介苗膀胱内灌注的推荐;(2)强化围手术期全身化疗的推荐;(3)将免疫疗法纳入局部晚期或转移性疾病的二线治疗。这些NCCN指南见解进一步讨论了影响将这些推荐纳入临床实践的因素。

相似文献

2
NCCN Guidelines® Insights: Bladder Cancer, Version 3.2024.NCCN 指南®洞察:膀胱癌,第 3.2024 版。
J Natl Compr Canc Netw. 2024 May;22(4):216-225. doi: 10.6004/jnccn.2024.0024.
6
Intravesical therapy for bladder cancer.膀胱癌的膀胱内治疗
Expert Opin Pharmacother. 2015 Apr;16(6):889-901. doi: 10.1517/14656566.2015.1024656. Epub 2015 Mar 14.
10
Superficial bladder cancer: part 2. Management.浅表性膀胱癌:第2部分。治疗
Expert Rev Anticancer Ther. 2007 Apr;7(4):567-81. doi: 10.1586/14737140.7.4.567.

引用本文的文献

10
Molecular classification of urothelial bladder carcinoma.尿路上皮膀胱癌的分子分类。
Mol Biol Rep. 2023 Sep;50(9):7867-7877. doi: 10.1007/s11033-023-08689-7. Epub 2023 Jul 31.

本文引用的文献

3
Effectiveness of Adjuvant Chemotherapy for Locally Advanced Bladder Cancer.局部晚期膀胱癌辅助化疗的疗效。
J Clin Oncol. 2016 Mar 10;34(8):825-32. doi: 10.1200/JCO.2015.64.1076. Epub 2016 Jan 19.
4
Cancer statistics, 2016.癌症统计数据,2016 年。
CA Cancer J Clin. 2016 Jan-Feb;66(1):7-30. doi: 10.3322/caac.21332. Epub 2016 Jan 7.
7
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency.错配修复缺陷肿瘤中的程序性死亡受体-1阻断
N Engl J Med. 2015 Jun 25;372(26):2509-20. doi: 10.1056/NEJMoa1500596. Epub 2015 May 30.
10
Pembrolizumab for the treatment of non-small-cell lung cancer.帕博利珠单抗治疗非小细胞肺癌。
N Engl J Med. 2015 May 21;372(21):2018-28. doi: 10.1056/NEJMoa1501824. Epub 2015 Apr 19.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验